Pulse nav.journalClub 활발한 토론 트렌드 탐색 연구자

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

개인정보 처리방침

홈 탐색 nav.journalClub 트렌드

⌘+K

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing | Synapse

September 26, 2018Open Access

DNA 시퀀싱에 의한 1차 결핵 약물에 대한 감수성 예측

Key Points

Key points are not available for this paper at this time.

Abstract

M. tuberculosis의 1차 약물에 대한 감수성에 대한 유전자형 예측이 이러한 약물에 대한 표현형 감수성과 상관관계가 있음을 발견했다. (빌 앤 멜린다 게이츠 재단 및 기타 기관의 지원을 받음.)

Read Full Paperexternally

Like

Bookmark

Share

View Full Paper

Cite This Study

Genomes Project Consortium Cryptic And The (수요일,) 이 질문을 연구했다.

synapsesocial.com/papers/69deefda7702a00918b0d367 https://doi.org/https://doi.org/10.1056/nejmoa1800474

Like

Bookmark

Share

View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study2016 · 34 citations
2Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations1997 · 336 citations
3Transmission of Extensively Drug-Resistant Tuberculosis in South Africa2017 · 293 citations
4Detection of Drug-Resistant Tuberculosis by Xpert MTB/RIF in Swaziland2015 · 185 citations
5Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study2011 · 1,019 citations